Gabelli Funds’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
103,000
+78,000
+312% +$1.36M 0.01% 818
2026
Q1
$479K Buy
+25,000
New +$543K ﹤0.01% 1046
2023
Q3
Sell
-11,000
Closed -$270K 1154
2023
Q2
$270K Buy
+11,000
New +$354K ﹤0.01% 981
2019
Q1
Sell
-8,135
Closed -$309K 1162
2018
Q4
$309K Hold
8,135
﹤0.01% 1033
2018
Q3
$349K Sell
8,135
-12,500
-61% -$437K ﹤0.01% 1056
2018
Q2
$454K Hold
20,635
﹤0.01% 1014
2018
Q1
$102K Buy
+20,635
New +$66.5K ﹤0.01% 1130

Other funds holding TNDM

Gabelli Funds's TNDM Position: Q2 2026 in Review

Gabelli Funds increased its Tandem Diabetes Care (TNDM) stake by 312% in Q2 2026, buying an estimated $1.36M and bringing the position to 103,000 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #818.

Gabelli Funds first reported a position in TNDM in Q1 2018 and has held it in 7 quarters since. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Gabelli Funds held 103,000 shares of Tandem Diabetes Care worth $1.55M as of Q2 2026.
  • Gabelli Funds bought 78,000 Tandem Diabetes Care shares in Q2 2026, an estimated $1.36M.
  • Tandem Diabetes Care made up 0.01% of Gabelli Funds's portfolio in Q2 2026, its #818 holding.
  • Gabelli Funds first reported a position in Tandem Diabetes Care in Q1 2018 and has held it in 7 quarters since.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.